<p>Alignment Healthcare（納斯達克股票代碼：ALHC - 獲取免費報告）在週三向投資者發佈的報告中，摩根大通將其目標價格從 17.00 美元上調至 18.00 美元，Benzinga 報道。該券商目前對該股票的評級為 “中性”。摩根大通的目標價格表明，相較於該股票的前一交易日收盤價，存在 5.51% 的潛在上漲空間。</p>
<p>其他一些研究分析師最近也對 ALHC 發佈了報告。Weiss Ratings 在 10 月 8 日的研究報告中重申了對 Alignment Healthcare 股票的 “賣出（d-）” 評級。華爾街 Zen 在 8 月 10 日的報告中將 Alignment Healthcare 的評級從 “買入” 下調至 “持有”。高盛集團在週一的報告中重申了 “買入” 評級，並對 Alignment Healthcare 股票設定了 22.00 美元的目標價格。瑞銀集團在 10 月 31 日的報告中將 Alignment Healthcare 的目標價格從 17.00 美元上調至 18.00 美元，並給予該股票 “中性” 評級。最後，巴克萊在 10 月 31 日的報告中將 Alignment Healthcare 的目標價格從 13.00 美元上調至 18.00 美元，並給予該股票 “等權重” 評級。一位分析師給予該股票 “強烈買入” 評級，七位分析師給予 “買入” 評級，四位分析師給予 “持有” 評級，一位分析師給予 “賣出” 評級。根據 MarketBeat 的數據，該股票目前的共識評級為 “適度買入”，共識目標價格為 19.85 美元。</p>
<p>獲取 <strong>Alignment Healthcare</strong> 警報：</p>
<p><strong>獲取我們對 ALHC 的最新股票分析</strong></p>
<h2>Alignment Healthcare 價格表現</h2>
<p>Alignment Healthcare 股票在週三的交易中下跌 0.03 美元，報 17.06 美元。該股票成交量為 1,392,839 股，而其平均成交量為 3,112,505 股。該公司的速動比率為 1.61，流動比率為 1.61，債務與股本比率為 1.99。該股票的市值為 34.1 億美元，市盈率為-142.13，貝塔值為 1.17。該公司的 50 日移動平均線為 16.94 美元，200 日移動平均線為 15.46 美元。Alignment Healthcare 的 52 周低點為 10.18 美元，52 周高點為 21.06 美元。</p>
<p>Alignment Healthcare（納斯達克股票代碼：ALHC - 獲取免費報告）最近在 10 月 30 日發佈了季度財報。該公司報告每股收益（EPS）為 0.02 美元，超出市場共識預期的-0.01 美元，超出幅度為 0.03 美元。Alignment Healthcare 的股本回報率為-16.23%，淨利潤率為-0.57%。該季度的營業收入為 9.937 億美金，而分析師預期為 9.809 億美金。去年同期，該公司每股收益為-0.14 美元。Alignment Healthcare 本季度的收入較去年同期增長了 43.5%。Alignment Healthcare 已設定 2025 財年的每股收益指導。2025 年第四季度的指導為每股收益。研究分析師預計 Alignment Healthcare 在當前財年將發佈-0.69 美元的每股收益。</p>
<h2>內部買賣</h2>
<p>在其他 Alignment Healthcare 的新聞中，內部人士 Hyong Kim 在 10 月 9 日的交易中出售了 51,379 股該股票。該股票的平均售價為 17.57 美元，總交易額為 902,729.03 美元。出售後，該內部人士直接持有該公司 362,333 股股票，估值約為 6,366,190.81 美元。此交易代表其持股比例減少了 12.42%。該出售在向證券交易委員會提交的文件中披露，相關文件可通過此鏈接訪問。此外，董事 Atlantic（Aln Hlth）L. General 在 9 月 17 日的交易中出售了 6,246,096 股該公司的股票。該股票的平均售價為 16.01 美元，總價值為 99,999,996.96 美元。出售後，該董事在公司持有 24,596,079 股股票，估值為 393,783,224.79 美元。此交易代表其持股比例減少了 20.25%。有關此出售的更多細節可在官方 SEC 披露中找到。在過去 90 天內，內部人士已出售公司股票 7,427,716 股，價值 119,650,069 美元。內部人士持有該股票的比例為 6.60%。</p>
<h2>Alignment Healthcare 的機構交易</h2>
<p>幾家機構投資者最近對該公司的持股進行了調整。Principal Financial Group Inc.在第三季度將其在 Alignment Healthcare 的股份增加了 40.1%。Principal Financial Group Inc.目前持有 167,376 股該公司的股票，價值 2,921,000 美元，此前在上一季度增持了 47,895 股。亞利桑那州退休系統在第三季度將其在 Alignment Healthcare 的股份增加了 33.1%。亞利桑那州退休系統目前持有 40,967 股該公司的股票，價值 715,000 美元，此前在上一季度增持了 10,195 股。紐約州共同退休基金在第三季度將其在 Alignment Healthcare 的股份增加了 3.1%。紐約州共同退休基金目前持有 207,461 股該公司的股票，價值 3,620,000 美元，此前在上一季度增持了 6,200 股。先鋒個性化指數管理公司在第三季度獲得了 Alignment Healthcare 的新頭寸，價值 242,000 美元。最後，Y Intercept Hong Kong Ltd 在第三季度獲得了 Alignment Healthcare 的新頭寸，價值 3,499,000 美元。對沖基金和其他機構投資者持有該公司 86.19% 的股票。</p>
<h2>Alignment Healthcare 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Alignment Healthcare, Inc.是一家技術驅動的醫療保險優勢公司，為美國老年人提供以消費者為中心的醫療保健平台。它通過醫療保險優勢計劃提供定製的醫療保健，以滿足多樣化老年人的需求。該公司成立於 2013 年，總部位於加利福尼亞州橙縣。</p>
<h2>推薦故事</h2>
<ul>
<li>我們更看好的五隻股票，而非 Alignment Healthcare</li>
<li>動盪市場中的資產配置策略</li>
<li>Spotify 發佈巨大的每股收益超預期：股價仍然大幅低於高點</li>
<li>現在購買的三隻最佳藍籌股</li>
<li>Stardust 的戰略鋰交易可能成為遊戲規則的改變者</li>
<li>如何計算股票利潤</li>
<li>價格震驚：為什麼金佰利的拋售反應過度</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 $1,000 在 Alignment Healthcare 嗎？</h2>
<p>在考慮 Alignment Healthcare 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Alignment Healthcare 並不在名單上。</p>
<p>雖然 Alignment Healthcare 目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

ALHC

<p>摩根大通已將 Alignment Healthcare（納斯達克代碼：ALHC）的目標價格從 17.00 美元上調至 18.00 美元，維持 “中性” 評級。這表明相較於前一交易日收盤價有 5.51% 的潛在上漲空間。其他分析師的評級各不相同，Weiss Ratings 給出 “賣出” 評級，而高盛則給予 “買入” 評級，目標價為 22.00 美元。該股票交易價格為 17.06 美元，市值為 34.1 億美元。近期的內部銷售和機構投資反映出市場對該公司的持續關注，該公司報告的年收入增長率為 43.5%</p>

<p>Alignment Healthcare (NASDAQ:ALHC - Get Free Report) had its price objective upped by JPMorgan Chase &amp; Co. from $17.00 to $18.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a &#34;neutral&#34; rating on the stock. JPMorgan Chase &amp; Co.'s price target indicates a potential upside of 5.51% from the stock's previous close.</p>
<div class="lb-trans"><p>Alignment Healthcare（納斯達克股票代碼：ALHC - 獲取免費報告）在週三向投資者發佈的報告中，摩根大通將其目標價格從 17.00 美元上調至 18.00 美元，Benzinga 報道。該券商目前對該股票的評級為 “中性”。摩根大通的目標價格表明，相較於該股票的前一交易日收盤價，存在 5.51% 的潛在上漲空間。</p>
</div><p>A number of other research analysts have also recently issued reports on ALHC. Weiss Ratings reiterated a &#34;sell (d-)&#34; rating on shares of Alignment Healthcare in a research note on Wednesday, October 8th. Wall Street Zen lowered Alignment Healthcare from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Sunday, August 10th. The Goldman Sachs Group reissued a &#34;buy&#34; rating and issued a $22.00 target price on shares of Alignment Healthcare in a report on Monday. UBS Group lifted their target price on Alignment Healthcare from $17.00 to $18.00 and gave the stock a &#34;neutral&#34; rating in a report on Friday, October 31st. Finally, Barclays lifted their target price on Alignment Healthcare from $13.00 to $18.00 and gave the stock an &#34;equal weight&#34; rating in a report on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $19.85.</p>
<div class="lb-trans"><p>其他一些研究分析師最近也對 ALHC 發佈了報告。Weiss Ratings 在 10 月 8 日的研究報告中重申了對 Alignment Healthcare 股票的 “賣出（d-）” 評級。華爾街 Zen 在 8 月 10 日的報告中將 Alignment Healthcare 的評級從 “買入” 下調至 “持有”。高盛集團在週一的報告中重申了 “買入” 評級，並對 Alignment Healthcare 股票設定了 22.00 美元的目標價格。瑞銀集團在 10 月 31 日的報告中將 Alignment Healthcare 的目標價格從 17.00 美元上調至 18.00 美元，並給予該股票 “中性” 評級。最後，巴克萊在 10 月 31 日的報告中將 Alignment Healthcare 的目標價格從 13.00 美元上調至 18.00 美元，並給予該股票 “等權重” 評級。一位分析師給予該股票 “強烈買入” 評級，七位分析師給予 “買入” 評級，四位分析師給予 “持有” 評級，一位分析師給予 “賣出” 評級。根據 MarketBeat 的數據，該股票目前的共識評級為 “適度買入”，共識目標價格為 19.85 美元。</p>
</div><p>Get <strong>Alignment Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Alignment Healthcare</strong> 警報：</p>
</div><p><strong>Get Our Latest Stock Analysis on ALHC</strong></p>
<div class="lb-trans"><p><strong>獲取我們對 ALHC 的最新股票分析</strong></p>
</div><h2>Alignment Healthcare Price Performance</h2>
<div class="lb-trans"><h2>Alignment Healthcare 價格表現</h2>
</div><p>Shares of Alignment Healthcare stock traded down $0.03 during trading on Wednesday, hitting $17.06. 1,392,839 shares of the stock traded hands, compared to its average volume of 3,112,505. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.99. The stock has a market cap of $3.41 billion, a price-to-earnings ratio of -142.13 and a beta of 1.17. The firm's fifty day moving average is $16.94 and its 200-day moving average is $15.46. Alignment Healthcare has a 52 week low of $10.18 and a 52 week high of $21.06.</p>
<div class="lb-trans"><p>Alignment Healthcare 股票在週三的交易中下跌 0.03 美元，報 17.06 美元。該股票成交量為 1,392,839 股，而其平均成交量為 3,112,505 股。該公司的速動比率為 1.61，流動比率為 1.61，債務與股本比率為 1.99。該股票的市值為 34.1 億美元，市盈率為-142.13，貝塔值為 1.17。該公司的 50 日移動平均線為 16.94 美元，200 日移動平均線為 15.46 美元。Alignment Healthcare 的 52 周低點為 10.18 美元，52 周高點為 21.06 美元。</p>
</div><p>Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings results on Thursday, October 30th. The company reported $0.02 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.03. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The business had revenue of $993.70 million for the quarter, compared to analyst estimates of $980.90 million. During the same period last year, the company earned ($0.14) EPS. Alignment Healthcare's revenue for the quarter was up 43.5% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. Research analysts expect that Alignment Healthcare will post -0.69 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Alignment Healthcare（納斯達克股票代碼：ALHC - 獲取免費報告）最近在 10 月 30 日發佈了季度財報。該公司報告每股收益（EPS）為 0.02 美元，超出市場共識預期的-0.01 美元，超出幅度為 0.03 美元。Alignment Healthcare 的股本回報率為-16.23%，淨利潤率為-0.57%。該季度的營業收入為 9.937 億美金，而分析師預期為 9.809 億美金。去年同期，該公司每股收益為-0.14 美元。Alignment Healthcare 本季度的收入較去年同期增長了 43.5%。Alignment Healthcare 已設定 2025 財年的每股收益指導。2025 年第四季度的指導為每股收益。研究分析師預計 Alignment Healthcare 在當前財年將發佈-0.69 美元的每股收益。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>內部買賣</h2>
</div><p>In other Alignment Healthcare news, insider Hyong Kim sold 51,379 shares of the stock in a transaction dated Thursday, October 9th. The stock was sold at an average price of $17.57, for a total transaction of $902,729.03. Following the sale, the insider directly owned 362,333 shares of the company's stock, valued at approximately $6,366,190.81. This trade represents a 12.42% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through this link. Also, Director Atlantic (Aln Hlth) L. General sold 6,246,096 shares of the firm's stock in a transaction dated Wednesday, September 17th. The shares were sold at an average price of $16.01, for a total value of $99,999,996.96. Following the sale, the director owned 24,596,079 shares in the company, valued at $393,783,224.79. This trade represents a 20.25% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 7,427,716 shares of company stock valued at $119,650,069 over the last 90 days. 6.60% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在其他 Alignment Healthcare 的新聞中，內部人士 Hyong Kim 在 10 月 9 日的交易中出售了 51,379 股該股票。該股票的平均售價為 17.57 美元，總交易額為 902,729.03 美元。出售後，該內部人士直接持有該公司 362,333 股股票，估值約為 6,366,190.81 美元。此交易代表其持股比例減少了 12.42%。該出售在向證券交易委員會提交的文件中披露，相關文件可通過此鏈接訪問。此外，董事 Atlantic（Aln Hlth）L. General 在 9 月 17 日的交易中出售了 6,246,096 股該公司的股票。該股票的平均售價為 16.01 美元，總價值為 99,999,996.96 美元。出售後，該董事在公司持有 24,596,079 股股票，估值為 393,783,224.79 美元。此交易代表其持股比例減少了 20.25%。有關此出售的更多細節可在官方 SEC 披露中找到。在過去 90 天內，內部人士已出售公司股票 7,427,716 股，價值 119,650,069 美元。內部人士持有該股票的比例為 6.60%。</p>
</div><h2>Institutional Trading of Alignment Healthcare</h2>
<div class="lb-trans"><h2>Alignment Healthcare 的機構交易</h2>
</div><p>Several institutional investors have recently made changes to their positions in the company. Principal Financial Group Inc. grew its stake in shares of Alignment Healthcare by 40.1% in the third quarter. Principal Financial Group Inc. now owns 167,376 shares of the company's stock worth $2,921,000 after acquiring an additional 47,895 shares in the last quarter. Arizona State Retirement System grew its stake in shares of Alignment Healthcare by 33.1% in the third quarter. Arizona State Retirement System now owns 40,967 shares of the company's stock worth $715,000 after acquiring an additional 10,195 shares in the last quarter. New York State Common Retirement Fund grew its stake in shares of Alignment Healthcare by 3.1% in the third quarter. New York State Common Retirement Fund now owns 207,461 shares of the company's stock worth $3,620,000 after acquiring an additional 6,200 shares in the last quarter. Vanguard Personalized Indexing Management LLC acquired a new position in shares of Alignment Healthcare in the third quarter worth $242,000. Finally, Y Intercept Hong Kong Ltd acquired a new position in shares of Alignment Healthcare in the third quarter worth $3,499,000. Hedge funds and other institutional investors own 86.19% of the company's stock.</p>
<div class="lb-trans"><p>幾家機構投資者最近對該公司的持股進行了調整。Principal Financial Group Inc.在第三季度將其在 Alignment Healthcare 的股份增加了 40.1%。Principal Financial Group Inc.目前持有 167,376 股該公司的股票，價值 2,921,000 美元，此前在上一季度增持了 47,895 股。亞利桑那州退休系統在第三季度將其在 Alignment Healthcare 的股份增加了 33.1%。亞利桑那州退休系統目前持有 40,967 股該公司的股票，價值 715,000 美元，此前在上一季度增持了 10,195 股。紐約州共同退休基金在第三季度將其在 Alignment Healthcare 的股份增加了 3.1%。紐約州共同退休基金目前持有 207,461 股該公司的股票，價值 3,620,000 美元，此前在上一季度增持了 6,200 股。先鋒個性化指數管理公司在第三季度獲得了 Alignment Healthcare 的新頭寸，價值 242,000 美元。最後，Y Intercept Hong Kong Ltd 在第三季度獲得了 Alignment Healthcare 的新頭寸，價值 3,499,000 美元。對沖基金和其他機構投資者持有該公司 86.19% 的股票。</p>
</div><h2>Alignment Healthcare Company Profile</h2>
<div class="lb-trans"><h2>Alignment Healthcare 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.</p>
<div class="lb-trans"><p>Alignment Healthcare, Inc.是一家技術驅動的醫療保險優勢公司，為美國老年人提供以消費者為中心的醫療保健平台。它通過醫療保險優勢計劃提供定製的醫療保健，以滿足多樣化老年人的需求。該公司成立於 2013 年，總部位於加利福尼亞州橙縣。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Alignment Healthcare</li>
<li>Asset Allocation Strategies in Volatile Markets</li>
<li>Spotify Posts Huge EPS Beat: Shares Are Still Down Big From Highs</li>
<li>The 3 Best Blue-Chip Stocks to Buy Now</li>
<li>Stardust's Strategic Lithium Deal Could Be a Game-Changer</li>
<li>How to Calculate Stock Profit</li>
<li>Sticker Shock: Why Kimberly-Clark's Sell-Off Is an Overreaction</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而非 Alignment Healthcare</li>
<li>動盪市場中的資產配置策略</li>
<li>Spotify 發佈巨大的每股收益超預期：股價仍然大幅低於高點</li>
<li>現在購買的三隻最佳藍籌股</li>
<li>Stardust 的戰略鋰交易可能成為遊戲規則的改變者</li>
<li>如何計算股票利潤</li>
<li>價格震驚：為什麼金佰利的拋售反應過度</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=ALHC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Alignment Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 $1,000 在 Alignment Healthcare 嗎？</h2>
</div><p>Before you consider Alignment Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Alignment Healthcare 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Alignment Healthcare 並不在名單上。</p>
</div><p>While Alignment Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Alignment Healthcare 目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

摩根大通對 Alignment Healthcare（納斯達克股票代碼：ALHC）的股價發佈了樂觀的預測